In the realm of medical science, hope often comes from unexpected places.  One man, Eric, was given a grim diagnosis: colon cancer that had spread to his liver.  At just 35 years old, his future looked bleak.  Yet, Eric had a dream.  He wanted to walk his daughter down the aisle on her wedding day.  This wish seemed impossible, but medicine is full of surprises.

  Medical advancements have made what was once unimaginable possible.  Twenty years ago, Eric's cancer was considered incurable.  Today, he is cancer-free, with two grown daughters and a son.  His story is not unique.  Thanks to rigorous research, about 25% of patients with stage IV colon cancer that has spread to the liver can now be cured.

  This progress didn't happen by accident.  It was the result of hard work and investment.  The U. S. government has been a major funder of cancer research.  Between 2016 and 2020, it provided 57% of global cancer research funding.  This investment has turned individual success stories into everyday realities.  It has transformed dire diagnoses into survivorship tales.  It has given patients access to cutting-edge treatments.

  But this progress is under threat.  Recent cuts to university funding could jeopardize future breakthroughs.  These cuts are not just about money.  They are about hope.  They are about the future of families facing devastating diagnoses.  They are about the potential to save lives.

  Consider the impact of these cuts.  They could lead to missed diagnoses, delayed treatments, and lives cut short.  They could slow down the progress that has made cancer a manageable disease for many.  They could make stories like Eric's less common.

  The stakes are high.  The cancer death rate has fallen by one-third between 1991 and 2020.  Childhood leukemia survival rates have soared from about 50% in the 1970s to over 90% today.  These gains are a testament to the power of research.  They are a reminder of what is at stake.

  Yet, there is more to be done.  Conditions like hypermobile Ehlers-Danlos syndrome (EDS) still lack effective treatments.  They are a reminder of the work that lies ahead.  They are a call to action.  They are a plea to continue investing in medical research.  They are a plea to keep the hope alive.

  The future of medical progress is in our hands.  It is up to us to ensure that stories like Eric's continue.  It is up to us to ensure that hope remains a powerful force in the fight against disease.

A Father's Promise: The Power of Medical Progress

Actions